HomeSGP • NASDAQ
add
SpyGlass Pharma Inc
Previous close
$25.91
Day range
$24.28 - $27.23
Year range
$20.16 - $32.44
Market cap
816.94M USD
Avg Volume
137.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.63M | 75.75% |
Net income | -12.56M | -49.48% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 107.44M | 560.41% |
Total assets | 115.87M | 396.90% |
Total liabilities | 10.17M | -9.60% |
Total equity | 105.70M | — |
Shares outstanding | 2.20M | — |
Price to book | -0.58 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.56M | -49.48% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2019
Headquarters
Website
Employees
65
